http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S57165382-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1374dd16777534b65ad4422333245af8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-935
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
filingDate 1981-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08cc131ed8a82d49cd5d79f8e408787e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a003e516b0070f4851f6e5ac45810acf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a3e031c2c78c88ee6aed81c1b9b7b78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc73a53703b5cdb6582ae13ea7614f2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1216d44ad651531644e2ea82b190b5c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c247b3bab7eff298cd96066158853b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fa29223188087f431fd9f445a813c48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45b45e663ab3ee9bb0604b862f44baa5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8f27821fb9224f44007b56410c4f427
publicationDate 1982-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S57165382-A
titleOfInvention Fluoro-pgi2 compound and its preparation
abstract NEW MATERIAL:The fluoro-PGI 2 compound of formulaI(R 1 is H or 1W10C alkyl; R 2 and R 3 are H or OH-protecting group; R 4 is F and R 5 and R 6 together represent a single bond, or R 6 is F and R 4 and R 5 together represent a single bond) or when R 1 is H, the non-toxic salt of the acid. n EXAMPLE: 7-Fluoro-PGI 2 methyl ester 11,15-diacetate. n USE: The compound exhibits blood platelet coagulation suppressing action, hypotensive action, smooth muscle relaxing action, etc., and is expected to be a drug. The compound having protected OH group is useful also as an intermediate of other compounds. n PROCESS: The compound of formulaIcan be prepared, e.g. by reacting 7-hydroxy- PGI 2 compound of formula II (R 11 is 1W10C alkyl; R 21 and R 31 are OH-protecting group) with the dialkylaminosulfate trifluoride of formula III (R 7 and R 8 are 1W5C alkyl, or R 7 and R 8 may together form a ring through a single bond or 0), and if necessary, eliminating the protecting group or hydrolyzing the product. n COPYRIGHT: (C)1982,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5538995-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8404917-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S57200378-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S57171988-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08208637-A
priorityDate 1981-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310

Total number of triples: 30.